Pfizer accelerates clinical trial plans for coronavirus drug

Human studies of an antiviral therapy Pfizer is developing could begin this fall, several months ahead of when the pharma originally expected.

Pfizer accelerates clinical trial plans for coronavirus drug
Human studies of an antiviral therapy Pfizer is developing could begin this fall, several months ahead of when the pharma originally expected.